查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800131

自动化微生物学检测市场：2025 年至 2030 年预测

Automated Microbiology Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

自动化微生物检测市场预计将从 2025 年的 78.65 亿美元成长到 2030 年的 125.19 亿美元，复合年增长率为 9.74%。

市场区隔：诊断技术领域中一个充满活力的细分市场，专注于简化微生物检测和鑑定的先进系统。该市场涵盖诊断技术、终端用户应用和区域趋势，并在临床诊断、研究和工业应用中发挥关键作用。截至2025年，市场将受到不断增长的需求、技术进步和法律规范的影响。本摘要介绍市场驱动因素、竞争动态和分析方法，旨在为行业专业人士提供深刻见解。

市场概况与驱动因素

医疗保健、製药和食品安全领域对快速、准确、高通量微生物检测的需求日益增长，推动了自动化微生物检测市场的发展。自动化系统透过减少人力、提高诊断准确性和缩短週转时间，从而提升效率。感染疾病的流行和对照护现场诊断（POCT）的需求日益增长，进一步推动了市场的成长。此外，整合软体和机器人等自动化技术的进步实现了无缝的工作流程，推动了其在临床实验室和研究机构中的应用。市场也受到严格监管标准的影响，这些标准旨在确保产品的可靠性和安全性，并塑造创新和合规策略。

市场分析方法

我们的市场规模估算结合了自下而上和自上而下的方法。二手资料研究透过产业报告、新闻稿和专有资料集识别关键参与者及其收益贡献。数据三角测量将这些发现与相关人员（包括製造商、供应商和经销商）的主要输入联繫起来。这种综合方法能够准确估算市场规模并进行预测，并以图表和图形等易于理解的格式呈现洞察，从而实现高效决策。我们也分析供需动态、销售趋势和法律规范，以提供对市场环境的整体情况。

竞争资讯

在竞争格局中，Bio-Rad Laboratories, Inc. 和 QIAGEN 等主要企业正透过强大的产品系列和策略成长倡议推动创新。这些公司正在投资先进的诊断技术，并专注于自动化，以提高检测的准确性和扩充性。市场占有率分析凸显了这些公司的优势，这些优势得益于财务稳定性和持续的研发投入。竞争策略包括产品多样化、技术升级和市场扩张联盟。这些公司也正在应对复杂的法规以确保合规，从而巩固其在全球市场中的地位。

最终用户和地理洞察

该市场服务于多元化的终端用户，包括临床实验室、医院、学术研究中心以及製药和食品安全等工业部门。由于感染疾病控制对自动化诊断的需求旺盛，临床实验室占据主导地位。从区域来看，市场涵盖北美、欧洲、亚太地区和世界其他地区，其中北美和欧洲凭藉先进的医疗基础设施和研发投入处于领先地位。由于医疗服务可近性和工业化的改善，亚太地区的新兴市场正展现出成长潜力。

自动化微生物检测市场有望实现成长，这得益于对高效诊断解决方案的需求以及自动化技术的进步。 Bio-Rad Laboratories 和 QIAGEN 等主要企业正在透过技术创新和策略措施塑造竞争格​​局。我们全面的市场分析，结合二手资料研究和相关人员的意见，提供了趋势、法规和机会的切实可行的见解。由于微生物检测在医疗保健和工业应用中发挥关键作用，因此对快速可靠的微生物检测日益增长的需求预计将推动市场扩张。

本报告的主要优点

  • 深入分析：深入了解主要和新兴地区的市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解主要企业采用的策略策略，并了解正确策略的市场渗透潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力进行策略决策并在动态环境中开闢新的业务流和收益。
  • 适合广泛的使用者：对于新兴企业、研究机构、顾问、中小企业和大型企业来说都是有益且具有成本效益的。

它有什么用途？

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 2020 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测细分市场和区域分析（包括国家）
  • 公司概况（尤其是趋势）、财务资讯和关键发展

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章自动化微生物检测市场（依解决方案）

  • 介绍
  • 硬体
  • 软体
  • 服务

6. 自动化微生物检测市场（依技术）

  • 介绍
  • 检测技术
  • DNA与RNA探针定序
  • DNA定序
  • 其他的

第七章 自动化微生物检测市场（依最终用户）

  • 介绍
  • 製药和生物技术公司
  • 临床实验室
  • 其他的

8. 自动微生物检测市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 其他的

第九章：竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章：公司简介

  • Bio-Rad Laboratories, Inc.
  • QIAGEN
  • BECKMAN COULTER
  • Becton Dickinson
  • bioMerieux
  • Interscience
  • Rapid Micro Biosystems, Inc.
  • Sigma-Aldrich

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061610957

The Automated Microbiology Market is expected to grow from USD 7.865 billion in 2025 to USD 12.519 billion in 2030, at a CAGR of 9.74%.

The Automated Microbiology market is a dynamic segment within the diagnostic technology landscape, focusing on advanced systems that streamline microbial testing and identification. This market encompasses diagnostic technologies, end-user applications, and geographical trends, serving critical roles in clinical diagnostics, research, and industrial applications. As of 2025, the market is shaped by evolving demand, technological advancements, and regulatory frameworks. This summary highlights key market drivers, competitive dynamics, and analytical approaches, providing insights for industry experts.

Market Overview and Drivers

The Automated Microbiology market is driven by the increasing need for rapid, accurate, and high-throughput microbial testing in healthcare, pharmaceuticals, and food safety. Automated systems enhance efficiency by reducing manual intervention, improving diagnostic precision, and accelerating turnaround times. The growing prevalence of infectious diseases and the demand for point-of-care diagnostics further propel market growth. Additionally, advancements in automation technologies, such as integrated software and robotics, enable seamless workflows, supporting adoption across clinical laboratories and research institutions. The market is also influenced by stringent regulatory standards that ensure product reliability and safety, shaping innovation and compliance strategies.

Market Analysis Approach

Market size estimation involves a combination of bottom-up and top-down methodologies. Secondary research identifies key players and their revenue contributions through industry reports, press releases, and proprietary datasets. Data triangulation methods correlate these findings with primary inputs from stakeholders, including manufacturers, suppliers, and distributors. This comprehensive approach ensures accurate market sizing and forecasting, with insights presented in accessible formats like charts and graphics for efficient decision-making. The analysis also examines supply-demand dynamics, sales trends, and regulatory frameworks, offering a holistic view of the market environment.

Competitive Intelligence

The competitive landscape features prominent players such as Bio-Rad Laboratories, Inc. and QIAGEN, which drive innovation through robust product portfolios and strategic growth initiatives. These companies invest in advanced diagnostic technologies, focusing on automation to enhance testing accuracy and scalability. Market share analysis highlights their dominance, supported by financial stability and ongoing investments in research and development. Competitive strategies include product diversification, technological upgrades, and partnerships to expand market reach. These players also navigate regulatory complexities to ensure compliance, strengthening their positions in the global market.

End-User and Geographical Insights

The market serves diverse end users, including clinical laboratories, hospitals, academic research centers, and industrial sectors like pharmaceuticals and food safety. Clinical laboratories dominate due to the high demand for automated diagnostics in infectious disease management. Geographically, the market spans North America, Europe, Asia Pacific, and other regions, with North America and Europe leading due to advanced healthcare infrastructure and research investments. Emerging markets in Asia Pacific show growth potential driven by increasing healthcare access and industrialization.

The Automated Microbiology market is poised for growth, fueled by the demand for efficient diagnostic solutions and technological advancements in automation. Key players like Bio-Rad Laboratories and QIAGEN shape the competitive landscape through innovation and strategic initiatives. Comprehensive market analysis, combining secondary research and stakeholder inputs, provides actionable insights into trends, regulations, and opportunities. As the need for rapid and reliable microbial testing intensifies, the market is expected to expand, driven by its critical role in healthcare and industrial applications.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Automated Microbiology Market Segmentation

By Solutions

  • Hardware
  • Software
  • Services

By Technology

  • Detection Technique
  • DNA & RNA Probe Seqeuncing
  • DNA Sequencing
  • Others

By End-User

  • Pharmaceutical & Biotech Companies
  • Clinical Laboratories
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. AUTOMATED MICROBIOLOGY MARKET BY SOLUTIONS

  • 5.1. Introduction
  • 5.2. Hardware
  • 5.3. Software
  • 5.4. Services

6. AUTOMATED MICROBIOLOGY MARKET BY TECHNOLOGY

  • 6.1. Introduction
  • 6.2. Detection Technique
  • 6.3. DNA & RNA Probe Sequencing
  • 6.4. DNA Sequencing
  • 6.5. Others

7. AUTOMATED MICROBIOLOGY MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Pharmaceutical & Biotech Companies
  • 7.3. Clinical Laboratories
  • 7.4. Others

8. AUTOMATED MICROBIOLOGY MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentian
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Bio-Rad Laboratories, Inc.
  • 10.2. QIAGEN
  • 10.3. BECKMAN COULTER
  • 10.4. Becton Dickinson
  • 10.5. bioMerieux
  • 10.6. Interscience
  • 10.7. Rapid Micro Biosystems, Inc.
  • 10.8. Sigma-Aldrich

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations